MOTS-c vs SS-31: Two Different Approaches to Mitochondrial Research

The short answer

MOTS-c is a mitochondrial-derived peptide: it is encoded within mitochondrial DNA and studied as a signalling molecule that communicates from the mitochondrion to the cell nucleus. SS-31 is a synthetic tetrapeptide studied for its affinity to cardiolipin, a phospholipid concentrated in the inner mitochondrial membrane. MOTS-c is studied as a signal; SS-31 is studied as a structural interaction at the membrane.

MOTS-c: a signal from the mitochondrion

MOTS-c is unusual because it is encoded inside mitochondrial DNA rather than in the cell nucleus. Published mechanistic work describes it as a retrograde signal - information travelling from mitochondrion outward - with observed effects on metabolic signalling pathways in cell and rodent models. Research interest centres on that signalling role and on how its expression changes under metabolic stress.

SS-31: a membrane-targeting design

SS-31 is a synthetic tetrapeptide whose research interest comes from where it accumulates. Published work describes an affinity for cardiolipin, a phospholipid found in the inner mitochondrial membrane, and studies its interaction with that membrane in models of mitochondrial dysfunction. The mechanism under investigation is structural and local rather than signalling and systemic.

What the evidence does and does not show

Both compounds sit at a similar evidence stage: mechanistic and largely preclinical, with cell-model and rodent work forming the bulk of the literature. Neither has the kind of large, long-duration human trial record that exists for older compound classes. Research designs treating either as an established intervention are not supported by the published literature.

Because the two engage mitochondrial biology at different levels - signalling versus membrane interaction - published work does not position them as substitutes for one another.